Article Details
Retrieved on: 2024-11-02 19:10:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights HAYA Therapeutics' innovative approach in biopharma, utilizing long non-coding RNAs (lncRNAs) to target gene expression for RNA-based therapies, emphasizing potency in conditions like fibrosis by modulating disease-driving cell states.
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here